Recent advances in carbohydrate-based paclitaxel delivery systems

被引:0
|
作者
Azar Ramezanpour
Legha Ansari
Vahid Rahimkhoei
Sina Sharifi
Ashkan Bigham
Zohre Mehri Lighvan
Jafar Rezaie
Sławomir Szafert
GholamReza Mahdavinia
Ali Akbari
Esmaiel Jabbari
机构
[1] Isfahan University of Technology,Department of Chemistry
[2] Urmia University of Medical Sciences,Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute
[3] Urmia University of Medical Sciences,Solid Tumor Research Center, Cellular and Molecular Medicine research Institute
[4] Massachusetts Eye and Ear and Schepens Eye Research Institute,Disruptive Technology Laboratory, Department of Ophthalmology
[5] Harvard Medical School,Department of Polymer Processing
[6] Institute of Polymers,Faculty of Chemistry
[7] Composites and Biomaterials,Polymer Research Laboratory, Department of Chemistry, Faculty of Science
[8] National Research Council (IPCB-CNR),Department of Chemical Engineering
[9] Iran Polymer and Petrochemical Institute,undefined
[10] University of Wrocław,undefined
[11] University of Maragheh,undefined
[12] University of South Carolina,undefined
来源
Polymer Bulletin | 2024年 / 81卷
关键词
Drug delivery; Carbohydrate polymers; Cancer therapy; Paclitaxel;
D O I
暂无
中图分类号
学科分类号
摘要
Paclitaxel (PTX) as the most important member of the taxane family is used against a wide range of cancers including breast, ovarian and lung cancers. However, the effectiveness of PTX in clinical practice is limited by its low water solubility and permeability in biological tissues. To address these limitations, PTX is formulated with Cremophor EL and dehydrated ethanol, known as Taxol®. Due to the adverse side effects of the formulation, efforts have been made in recent years to develop alternative PTX formulations. Polysaccharides, due to their low toxicity and biocompatibility, biodegradability, and ease of chemical modification are an excellent alternative to Cremophor EL for formulating PTX. This review focuses on recent advances to develop PTX formulations based on polysaccharides.
引用
收藏
页码:1043 / 1069
页数:26
相关论文
共 50 条
  • [21] Carbohydrate-based click polycations for siRNA delivery
    Xue, Lian
    Reineke, Theresa
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [22] Advances in the Industrial Application of Enzymes on Carbohydrate-Based Materials
    Eggleston, Gillian
    INDUSTRIAL APPLICATION OF ENZYMES ON CARBOHYDRATE-BASED MATERIAL, 2007, 972 : 1 - 16
  • [23] Recent trends in the design of carbohydrate-based conjugate vaccines
    Berti, Francesco
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [24] Carbohydrate-based templates for synthetic vaccines and drug delivery
    McGeary, RP
    Jablonkai, I
    Toth, I
    TETRAHEDRON, 2001, 57 (41) : 8733 - 8742
  • [25] Carbohydrate-Based Organocatalysts: Recent Developments and Future Perspectives
    Mishra, Amrita
    Mishra, Nidhi
    Tiwari, Vinod K.
    CURRENT ORGANIC SYNTHESIS, 2016, 13 (02) : 176 - 219
  • [26] Advances in carbohydrate-based polymers for the design of suture materials: A review
    de la Harpe, Kara M.
    Kondiah, Pierre P. D.
    Marimuthu, Thashree
    Choonara, Yahya E.
    CARBOHYDRATE POLYMERS, 2021, 261
  • [27] Carbohydrate-based materials for targeted delivery of drugs and genes to the liver
    Ahmed, Marya
    Narain, Ravin
    NANOMEDICINE, 2015, 10 (14) : 2263 - 2288
  • [28] Recent Developments in Synthetic Carbohydrate-Based Diagnostics, Vaccines, and Therapeutics
    Fernandez-Tejada, Alberto
    Canada, F. Javier
    Jimenez-Barbero, Jesus
    CHEMISTRY-A EUROPEAN JOURNAL, 2015, 21 (30) : 10616 - 10628
  • [29] Recent Developments on Carbohydrate-based Anti-infective Agents
    Tripathi, Rama P.
    Upadhyaya, Kapil
    Singh, Kartikey
    Tiwari, Vinod K.
    TRENDS IN CARBOHYDRATE RESEARCH, 2015, 7 (04) : 1 - 21
  • [30] Recent progress and advanced technology in carbohydrate-based drug development
    Pan, Lin
    Cai, Chao
    Liu, Chanjuan
    Liu, Di
    Li, Guoyun
    Linhardt, Robert J.
    Yu, Guangli
    CURRENT OPINION IN BIOTECHNOLOGY, 2021, 69 : 191 - 198